CLX Clorox Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
16:03
Jun 05
Jun 05
The author notes unusual large moves in megacap staples and pharma stocks but provides no personal position or forward-looking call.
LOW
23:55
May 28
May 28
Reports CEO resignation for health reasons, a management change with potential strategic implications.
MED
19:30
May 03
May 03
Clorox reports flat revenue and management is cutting earnings forecasts in an inflationary environment, signaling declining unit sales. Consumer staples usually hold up in inflation, but here the core business is shrinking – a classic profit margin squeeze and volume loss. If the average consumer is pulling back, non-discretionary staples like Clorox can still underperform, making a short/bearish stance sensible while the broader market rallies. Inflation could allow pricing power to offset volume; a geopolitical shift might boost demand for cleaning products; short squeezes on a stable dividend stock.
LOW
11:02
May 01
May 01
A +6 upvoted comment highlights CLX (Clorox) at 14 P/E, 5.7% dividend yield, calling it a “boomer stock” to buy low. Defensive, high-dividend stocks tend to outperform in uncertain, rate-cut environments; the value proposition is clear. The community sees CLX as a safe haven with attractive valuation and yield, suitable for a “buy and forget” approach. Consumer staple stocks lag in risk-on rallies; one comment does not constitute broad consensus.
LOW
00:47
Feb 28
Feb 28
Author discloses CLX as a current long position contributing to a 3% daily portfolio gain; no catalyst or reasoning provided.
MED
18:59
Feb 12
Feb 12
Author discloses a large current long position in CLX as part of a defensive consumer staples overweight, consistent with a broader risk-off portfolio orientation.
MED
18:42
Feb 12
Feb 12
Long CLX as author discloses a current profitable position, driven by a stated rotation from Mag 7 and banks into defensive consumer staples value plays.
MED
17:44
Feb 11
Feb 11
Buy CLX as a consumer staples play with strong year-to-date performance, given speaker's 12% portfolio allocation.
MED
20:38
Feb 06
Feb 06
Buy CLX as a defensive consumer staples name showing a technical breakout; diversified product portfolio across cleaning, food, personal care, and filtration provides defensive characteristics.
MED
About CLX Analyst Coverage
Buzzberg tracks CLX (Clorox) across 4 sources. 6 bullish vs 1 bearish calls from 4 analysts. Sentiment: predominantly bullish (56%). 9 total trade ideas tracked. Latest voices: BarbarianCap, u/SnowSilent7695, r/wallstreetbets community.